Robert E. Gerl
Impact in
- Toxicology top 10%
-
- Cell death mechanisms and regulation
- Melanoma and MAPK Pathways
- RNA Interference and Gene Delivery
- Protein Kinase Regulation and GTPase Signaling
Papers in
- Oncology 3
- Cancer-related Molecular Pathways 2
- Cytokine Signaling Pathways and Interactions 1
-
- Cancer Mechanisms and Therapy 1
- Co-authors
- John W. Schrader (2 shared papers)Xuecui Guo (1 shared paper)John Silke (3 shared papers)Paul G. Ekert (2 shared papers)David Lawrence Vaux (3 shared papers)Christine J. Hawkins (2 shared papers)Hitto Kaufmann (2 shared papers)Stuart H. Read (2 shared papers)
In The Last Decade
Robert E. Gerl
8 papers receiving 720 citations
Peers
Comparison fields: 5 of 100
- Toxicology 23
- Molecular Biology 442
- Drug Discovery 1
- Immunology 114
- Cancer Research 73
Countries citing papers authored by Robert E. Gerl
This map shows the geographic impact of Robert E. Gerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Gerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Gerl more than expected).
Fields of papers citing papers by Robert E. Gerl
This network shows the impact of papers produced by Robert E. Gerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Gerl. The network helps show where Robert E. Gerl may publish in the future.
Co-authors
The 16 scholars most cited alongside Robert E. Gerl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 346 | |
| 2 | 2004 | 157 | |
| 3 | 1998 | 90 | |
| 4 | 2003 | 68 | |
| 5 | 2000 | 55 | |
| 6 | 2008 | 25 | |
| 7 | Apaf-1, Caspase-2 and Caspase-9 accelerate apoptosis, but do not determine whether factor-deprived cells die | 2004 | 1 |
| 8 | 2005 | 1 |
About Robert E. Gerl
Robert E. Gerl is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Aging and Immunology, having authored 8 papers that have together received 743 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Cancer-related Molecular Pathways (2 papers), Phagocytosis and Immune Regulation (2 papers), Melanoma and MAPK Pathways (2 papers), Cancer Mechanisms and Therapy (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper) and Genetics, Aging, and Longevity in Model Organisms (1 paper). The work is most often cited by research in Toxicology (23 citations), Molecular Biology (442 citations), Drug Discovery (1 citation), Immunology (114 citations) and Cancer Research (73 citations). Robert E. Gerl has collaborated with scholars based in Australia and Canada. Frequent co-authors include John W. Schrader, Xuecui Guo, John Silke, Paul G. Ekert, David Lawrence Vaux, Christine J. Hawkins, Hitto Kaufmann, Stuart H. Read, Vanessa S. Marsden and Sharad Kumar. Their work appears in journals such as Journal of Biological Chemistry, Acta Oncologica, The Journal of Cell Biology, Journal of Molecular Biology and Pediatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.